1. Home
  2. NWL vs GLUE Comparison

NWL vs GLUE Comparison

Compare NWL & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newell Brands Inc.

NWL

Newell Brands Inc.

HOLD

Current Price

$4.91

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

Logo Monte Rosa Therapeutics Inc.

GLUE

Monte Rosa Therapeutics Inc.

HOLD

Current Price

$17.93

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWL
GLUE
Founded
1903
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
NWL
GLUE
Price
$4.91
$17.93
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$4.97
$32.00
AVG Volume (30 Days)
9.0M
842.1K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
7.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,742,200,000.00
$123,672,000.00
Revenue This Year
$1.19
N/A
Revenue Next Year
$1.58
$2.45
P/E Ratio
N/A
$72.42
Revenue Growth
11.14
63.54
52 Week Low
$3.07
$4.12
52 Week High
$6.64
$25.77

Technical Indicators

Market Signals
Indicator
NWL
GLUE
Relative Strength Index (RSI) 71.75 49.49
Support Level $4.83 $17.66
Resistance Level $5.14 $18.66
Average True Range (ATR) 0.28 1.10
MACD 0.16 -0.12
Stochastic Oscillator 94.72 44.71

Price Performance

Historical Comparison
NWL
GLUE

About NWL Newell Brands Inc.

Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).

Share on Social Networks: